Nicholas Eugene Perkins, DO | |
701 Grove Rd, Greenville, SC 29605-4210 | |
(864) 455-4411 | |
(864) 455-4480 |
Full Name | Nicholas Eugene Perkins |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 17 Years |
Location | 701 Grove Rd, Greenville, South Carolina |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1063706547 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208M00000X | Hospitalist | 1487 (South Carolina) | Primary |
207R00000X | Internal Medicine | 1487 (South Carolina) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
Prisma Health Greenville Memorial Hospital | Greenville, SC | Hospital |
Prisma Health Patewood Hospital | Greenville, SC | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Prisma Health University Medical Group | 8325950983 | 2201 |
News Archive
Taro Pharmaceutical Industries Ltd. announced that it has been granted an Investigational New Drug ("IND") exemption by the United States Food and Drug Administration, ("FDA"), to permit clinical studies on T2000 (1,3-dimethoxymethyl-5,5-diphenyl-barbituric acid), one of a class of non-sedating barbiturate compounds currently in development by the Company.
Multicultural dynamics. Economic disparities. LGTBQ subtleties. Single-parent prevalence. Diversification of the American family is happening at an unprecedented rate, and while awareness of this increased diversity rises, research for what impact it has on parenting adolescents has been limited.
Far from being a pitchfork-wielding populist who wants to raze Washington, Romney said he would work with the people he finds there. ... He bragged that in his old job as governor, he met with Democrats every week. He boasted about his bipartisan health care bill. ... he gave us a hint of a strong center-right pragmatic approach.
Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced that it has entered into a definitive agreement to sell its specialty pharmaceutical business to the sigma-tau Group for $300 million plus an additional amount of up to $27 million based on success milestones. Enzon will also receive royalties of 5 to 10 percent on incremental net sales above a 2009 baseline amount from Enzon's four marketed specialty pharmaceutical products through 2014.
Rituximab, a drug used to treat cancer and arthritis, may help patients with antiphospholipid antibodies (aPLs) who suffer from aPL-related clinical problems that do not respond to anticoagulation, such as cardiac disease and kidney disease, according to a new study by rheumatology researchers at Hospital for Special Surgery. The study appears online ahead of print, in the journal Arthritis and Rheumatism.
› Verified 6 days ago
Entity Name | Prisma Health University Medical Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1295763217 PECOS PAC ID: 8325950983 Enrollment ID: O20031103000238 |
News Archive
Taro Pharmaceutical Industries Ltd. announced that it has been granted an Investigational New Drug ("IND") exemption by the United States Food and Drug Administration, ("FDA"), to permit clinical studies on T2000 (1,3-dimethoxymethyl-5,5-diphenyl-barbituric acid), one of a class of non-sedating barbiturate compounds currently in development by the Company.
Multicultural dynamics. Economic disparities. LGTBQ subtleties. Single-parent prevalence. Diversification of the American family is happening at an unprecedented rate, and while awareness of this increased diversity rises, research for what impact it has on parenting adolescents has been limited.
Far from being a pitchfork-wielding populist who wants to raze Washington, Romney said he would work with the people he finds there. ... He bragged that in his old job as governor, he met with Democrats every week. He boasted about his bipartisan health care bill. ... he gave us a hint of a strong center-right pragmatic approach.
Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced that it has entered into a definitive agreement to sell its specialty pharmaceutical business to the sigma-tau Group for $300 million plus an additional amount of up to $27 million based on success milestones. Enzon will also receive royalties of 5 to 10 percent on incremental net sales above a 2009 baseline amount from Enzon's four marketed specialty pharmaceutical products through 2014.
Rituximab, a drug used to treat cancer and arthritis, may help patients with antiphospholipid antibodies (aPLs) who suffer from aPL-related clinical problems that do not respond to anticoagulation, such as cardiac disease and kidney disease, according to a new study by rheumatology researchers at Hospital for Special Surgery. The study appears online ahead of print, in the journal Arthritis and Rheumatism.
› Verified 6 days ago
Entity Name | Greenville Health System |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1568532513 PECOS PAC ID: 8123938131 Enrollment ID: O20031212000723 |
News Archive
Taro Pharmaceutical Industries Ltd. announced that it has been granted an Investigational New Drug ("IND") exemption by the United States Food and Drug Administration, ("FDA"), to permit clinical studies on T2000 (1,3-dimethoxymethyl-5,5-diphenyl-barbituric acid), one of a class of non-sedating barbiturate compounds currently in development by the Company.
Multicultural dynamics. Economic disparities. LGTBQ subtleties. Single-parent prevalence. Diversification of the American family is happening at an unprecedented rate, and while awareness of this increased diversity rises, research for what impact it has on parenting adolescents has been limited.
Far from being a pitchfork-wielding populist who wants to raze Washington, Romney said he would work with the people he finds there. ... He bragged that in his old job as governor, he met with Democrats every week. He boasted about his bipartisan health care bill. ... he gave us a hint of a strong center-right pragmatic approach.
Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced that it has entered into a definitive agreement to sell its specialty pharmaceutical business to the sigma-tau Group for $300 million plus an additional amount of up to $27 million based on success milestones. Enzon will also receive royalties of 5 to 10 percent on incremental net sales above a 2009 baseline amount from Enzon's four marketed specialty pharmaceutical products through 2014.
Rituximab, a drug used to treat cancer and arthritis, may help patients with antiphospholipid antibodies (aPLs) who suffer from aPL-related clinical problems that do not respond to anticoagulation, such as cardiac disease and kidney disease, according to a new study by rheumatology researchers at Hospital for Special Surgery. The study appears online ahead of print, in the journal Arthritis and Rheumatism.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Nicholas Eugene Perkins, DO 300 E Mcbee Ave Fl 4, Greenville, SC 29601-2842 Ph: (864) 522-8603 | Nicholas Eugene Perkins, DO 701 Grove Rd, Greenville, SC 29605-4210 Ph: (864) 455-4411 |
News Archive
Taro Pharmaceutical Industries Ltd. announced that it has been granted an Investigational New Drug ("IND") exemption by the United States Food and Drug Administration, ("FDA"), to permit clinical studies on T2000 (1,3-dimethoxymethyl-5,5-diphenyl-barbituric acid), one of a class of non-sedating barbiturate compounds currently in development by the Company.
Multicultural dynamics. Economic disparities. LGTBQ subtleties. Single-parent prevalence. Diversification of the American family is happening at an unprecedented rate, and while awareness of this increased diversity rises, research for what impact it has on parenting adolescents has been limited.
Far from being a pitchfork-wielding populist who wants to raze Washington, Romney said he would work with the people he finds there. ... He bragged that in his old job as governor, he met with Democrats every week. He boasted about his bipartisan health care bill. ... he gave us a hint of a strong center-right pragmatic approach.
Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced that it has entered into a definitive agreement to sell its specialty pharmaceutical business to the sigma-tau Group for $300 million plus an additional amount of up to $27 million based on success milestones. Enzon will also receive royalties of 5 to 10 percent on incremental net sales above a 2009 baseline amount from Enzon's four marketed specialty pharmaceutical products through 2014.
Rituximab, a drug used to treat cancer and arthritis, may help patients with antiphospholipid antibodies (aPLs) who suffer from aPL-related clinical problems that do not respond to anticoagulation, such as cardiac disease and kidney disease, according to a new study by rheumatology researchers at Hospital for Special Surgery. The study appears online ahead of print, in the journal Arthritis and Rheumatism.
› Verified 6 days ago
Hanaa Benchekroun Belabbes, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 701 Grove Rd Fl 5, Greenville, SC 29605 Phone: 864-455-4411 Fax: 864-455-4480 | |
Artur Adam Charowski, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 20 Medical Ridge Dr, Greenville, SC 29605 Phone: 864-220-7270 Fax: 864-220-7290 | |
Robert Brunson Cartledge Jr., M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 255 Enterprise Blvd Ste 101, Greenville, SC 29615 Phone: 864-454-8120 Fax: 644-548-1258 | |
Dr. Jennifer Erin Harris, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 701 Grove Rd, Greenville, SC 29605 Phone: 864-455-7000 Fax: 864-455-4480 | |
Thomas Clifford Turner, Hospitalist Medicare: Medicare Enrolled Practice Location: 701 Grove Rd Fl 5, Greenville, SC 29605 Phone: 864-455-4411 Fax: 864-455-4480 | |
Dr. Laila Alexandria Hussein, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 701 Grove Rd Fl 5, Greenville, SC 29605 Phone: 864-455-4411 Fax: 864-455-4480 |